Cover Image
市場調查報告書

維他命D檢驗的全球市場:2015年∼2019年

Global Vitamin D Testing Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 229565
出版日期 內容資訊 英文 72 Pages
訂單完成後即時交付
價格
Back to Top
維他命D檢驗的全球市場:2015年∼2019年 Global Vitamin D Testing Market 2015-2019
出版日期: 2015年07月22日 內容資訊: 英文 72 Pages
簡介

全球維他命D檢驗市場,預計從2014年到2019年之間,以7.57%的年複合成長率擴大。

本報告提供全球維他命D檢驗市場的相關調查、市場規模與其預測、場成長要素和課題、主要供應商分析等資訊彙整市。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 各檢驗類型的市場分類

  • 25-羥維生素D檢驗
  • 1,25-羥維生素D檢驗

第8章 各檢驗方法類型的市場分類

  • 免疫分析 (免疫測量)
  • 直接檢測

第9章 各終端用戶的市場分類

  • 全球維他命D檢驗市場:各終端用戶

第10章 地理區分

  • 全球維他命D檢驗市場:各地區
  • 南北美洲
    • 市場規模與預測
  • 歐洲、中東、非洲地區
    • 市場規模與預測
  • 亞太地區
    • 市場規模與預測

第11章 購買標準

第12章 市場成長因素

第13章 成長因素與其影響

第14章 市場課題

第15章 成長因素與課題的影響

第16章 市場趨勢

第17章 趨勢與其影響

第18章 業者情勢

  • 競爭模式
    • 主要消息
    • M&A
  • 市場佔有率分析
  • 其他卓越供應商

第19章 主要供應商分析

  • Abbott Diagnostics
  • DiaSorin
  • bioMeriux
  • Siemens Healthcare Diagnostics
  • Roche Diagnostics

第20章 相關報告

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR6510

About Vitamin D Testing

Vitamin D is a naturally occurring, fat-soluble, biologically inert hormone precursor that exists in two primary forms: vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). Its main biologic function is to maintain calcium and phosphorus concentrations as it is essential for the overall bone health. Vitamin D has a number of other physiological roles, including retaining muscle strength, moderating immune function, regulating cellular differentiation, and reducing inflammation. Vitamin D test, also called 25-Hydroxy test, is used to measure the amount of vitamin in the bloodstream to rule out vitamin D deficiency. It can help determine the bone weakness, bone malformation, or abnormal metabolism of calcium (reflected by abnormal calcium, phosphorus, and PTH levels) as a result of a deficiency or excess of vitamin D.

Technavio's analysts forecast the global vitamin D testing market to grow at a CAGR of 7.57% during the period 2014-2019.

Covered in this Report

The report covers the present scenario and the growth prospects of the global vitamin D testing market for the period 2015-2019. To calculate the market size, the report considers revenue generated through vitamin D tests.

Technavio's report, Global Vitamin D Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, APAC, and EMEA; it also covers the market landscape and its growth prospects over the coming years.

The report includes a discussion of the key vendors operating in this market.

Key Geographies

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Abbott
  • BioMerieux
  • Diasorin
  • F. Hoffmann-La Roche
  • Siemens

Other Prominent Vendors

  • DIAsource ImmunoAssays
  • Gold Standard Diagnostics
  • Immunodiagnostic Systems Holdings
  • Ortho Clinical Diagnostics Inc.
  • Qualigen
  • Quest Diagnostics
  • Tosoh Bioscience

Market Driver

  • Ageing Population and Chronic Diseases
  • For a full, detailed list, view our report

Market Challenge

  • Declining Prices in Developed Countries
  • For a full, detailed list, view our report

Market Trend

  • Introduction of Novel Technology
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Type of Test

    • 07.1.1. 25-Hydroxy Vitamin D Test
    • 07.1.2. 1,25-Hydroxy Vitamin D Test

08. Market Segmentation by Type of Method

    • 08.1.1. Immunoassays
    • 08.1.2. Direct Detection Methods

09. Market Segmentation by End-user

  • 09.1. Global Vitamin D Testing Market by End-user

10. Geographical Segmentation

  • 10.1. Global Vitamin D Testing Market by Geographical Segmentation 2014-2019
  • 10.2. Vitamin D Testing Market in Americas
    • 10.2.1. Market Size and Forecast
  • 10.3. Vitamin D Testing Market in EMEA
    • 10.3.1. Market Size and Forecast
  • 10.4. Vitamin D Testing Market in APAC
    • 10.4.1. Market Size and Forecast

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

  • 18.1. Competitive Scenario
    • 18.1.1. Key News
    • 18.1.2. Mergers and Acquisitions
  • 18.2. Market Share Analysis 2014
  • 18.3. Other Prominent Vendors

19. Key Vendor Analysis

  • 19.1. Abbott Diagnostics
    • 19.1.1. Key Facts
    • 19.1.2. Business Overview
    • 19.1.3. Geographical Presence
    • 19.1.4. SWOT Analysis
  • 19.2. DiaSorin
    • 19.2.1. Key Facts
    • 19.2.2. Business Overview
    • 19.2.3. Business Segmentation by Revenue 2013
    • 19.2.4. Business Segmentation by Revenue 2012 and 2013
    • 19.2.5. Geographical Segmentation by Revenue 2013
    • 19.2.6. Business Strategy
    • 19.2.7. Recent Developments
    • 19.2.8. SWOT Analysis
  • 19.3. bioMeriux
    • 19.3.1. Key Facts
    • 19.3.2. Business Overview
    • 19.3.3. Business Segmentation by Revenue 2013
    • 19.3.4. Geographical Segmentation by Revenue 2013
    • 19.3.5. Business Strategy
    • 19.3.6. Recent Developments
    • 19.3.7. SWOT Analysis
  • 19.4. Siemens Healthcare Diagnostics
    • 19.4.1. Key Facts
    • 19.4.2. Business Overview
    • 19.4.3. SWOT Analysis
  • 19.5. Roche Diagnostics
    • 19.5.1. Key Facts
    • 19.5.2. Business Overview
    • 19.5.3. Business Segmentation by Revenue 2014
    • 19.5.4. Business Segmentation by Revenue 2013 and 2014
    • 19.5.5. Geographical Segmentation by Revenue 2014
    • 19.5.6. Business Strategy
    • 19.5.7. Recent Developments
    • 19.5.8. SWOT Analysis

20. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Vitamin D Testing Market 2015-2019 ($ millions)
  • Exhibit 3: Consequences of Vitamin D Deficiency
  • Exhibit 4: Global Guidelines for Vitamin D Test Range
  • Exhibit 5: Recommended Daily Intakes of Vitamin D for Global Population
  • Exhibit 6: Upper Limits of Vitamin D Intakes for Global Population
  • Exhibit 7: Segmentation of Global Vitamin D Testing Market by Type of Test
  • Exhibit 8: Segmentation of Global Vitamin D Testing Market by Type
  • Exhibit 9: Segmentation of Global Vitamin D Testing Market by Type of Method
  • Exhibit 10: Segmentation of Global Vitamin D Testing Market by End-user
  • Exhibit 11: Segmentation of Global Vitamin D Testing Market by End-user 2014
  • Exhibit 12: Vitamin D Market in Americas 2014-2019 ($ millions)
  • Exhibit 13: Vitamin D Market in US by Volume 2014-2019 (million units)
  • Exhibit 14: Vitamin D Market in EMEA by Revenue 2014-2019 ($ millions)
  • Exhibit 15: Vitamin D Market in EMEA by Volume 2014-2019 (million units)
  • Exhibit 16: Vitamin D Market in APAC by Revenue 2014-2019 ($ millions)
  • Exhibit 17: Abbott Diagnostics: Key Takeaways
  • Exhibit 18: bioMerieux: Key Takeaways
  • Exhibit 19: DiaSorin: Key Takeaways
  • Exhibit 20: Siemens: Key Takeaways
  • Exhibit 21: Roche Diagnostics: Key Takeaways
  • Exhibit 22: Abbott Diagnostics: Geographical Presence
  • Exhibit 23: DiaSorin: Business Segmentation by Revenue 2013
  • Exhibit 24: DiaSorin: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 25: DiaSorin: Geographical Segmentation by Revenue 2013
  • Exhibit 26: bioMeriux: Business Segmentation by Revenue 2013
  • Exhibit 27: bioMeriux: Geographical Segmentation by Revenue 2013
  • Exhibit 28: Roche Diagnostics: Business Segmentation by Revenue 2014
  • Exhibit 29: Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billion)
  • Exhibit 30: Roche Diagnostics: Geographical Segmentation by Revenue 2014
Back to Top